Ranbaxy Laboratories new owner of Terapia

Ranbaxy Laboratories Limited announced the completion of the purchase of 96.7 percent of Terapia S.A's shares by Ranbaxy Netherlands BV, after the transaction was approved by the Romanian Competition Council (CCR). Previously, ... More


SIF Banat-Crisana became significant shareholder in Biofarm

SIF Banat-Crisana last Thursday reached a share of 10 per cent in the capital of the pharmaceutical company Biofarm, following several transactions carried on through the Bucharest Stock Exchange (BVB). SIF Banat-Crisana ... More


Avon Opens USD 12 Million Regional Distribution Center In Chiajna

Avon Romania inaugurated the new Regional Distribution Center in Chiajna, after an investment of USD 12 million. The center will process orders for Romania and other four countries in the region: Bulgaria, Moldova, FYR Macedonia ... More


Pharmaceutical Market Reaches USD 421 Million For Purchasing Price

According to research company Cegedim, the Romanian pharmaceutical market reached USD 363 million producer price, a 7 percent increase compared to the similar interval last year, and USD 421 million purchase price. For the ... More


Aroma to pay '05 div of 0.23 levs per share

A June 28 general meeting of the shareholders of Aroma, the Bulgarian cosmetics company, will vote on a proposal to distribute dividend of 0.23 levs per share. The company will pay out as dividend 1.187 mln levs from last year's ... More


Antibiotice Iasi privatisation announcement to be published in September

The Authority for State Asset Resolution (AVAS) will appoint the members of the privatisation commission for Antibiotice Iasi, the most important company in the institution’s portfolio, within 30 days, and the privatisation ... More


Biofarm Co. expects around 18 million euros in turnover in 2006

Medicine producer Biofarm Bucharest estimates roughly 17.7 million euros in turnover in 2006, climbing 24 percent from 2005, the Ziarul Financiar reported on Tuesday. "The rise in turnover this year is based on the launching of ... More


Stada not interested in Pliva

German generic pharmaceutical company Stada Arzeneimittel AG is not interested in Pliva takeover, as reported by media in Croatia quoting Germany's newspaper Platow Brief, which was later denied by Stada. Launching of the ... More


Drug maker Biovet Q1 sales double

Biovet, the Peshtera-based drug company, said sales doubled y/y to 20.06 mln levs in Q1. Profit fell to 29,000 levs from 441,000 levs a year ago. Interest costs rose sevenfold to 1.528 mln levs. Biovet expanded its business scope ... More


Pliva Works on Organic Growth

Pliva announced that it has launched in the key markets a series of new medication, which would contribute to achieving the planned organic growth, Croatia Today reports. The most important medications launched by Pliva in ... More


Balgarska Roza-Sevtopolis to double cap

Balgarska Roza-Sevtopolis, the producer of essential oils, perfumery and cosmetics, said it will double capital to 6.032 mln levs through the issue of 3.016 mln new shares with a nominal value of 1 lev and issue price of 3 levs. ... More


Drug distributor offerings nears bourse listing

Bulgaria's Financial Supervision Commission has okayed the prospectus for the secondary offering of drug distributor Commercial League National Pharma Center Inc., the penultimate step to the listing of the shares on the local ... More


Actavis invests EUR 16.6 million in Zdravlje since 2003

Iceland’s Actavis Group has invested EUR 16.6 million in Serbia’s third-largest drug maker, Zdravlje, since it acquired the Leskovac-based firm in 2003, Pregled reported yesterday. Actavis pledged a EUR 20 million ... More


Montero intends to take over Antibiotice

Pharmaceuticals Group Montero active in drug distribution and retail trade, together with Phonix Laboratorium Hungary are interested in taking over the majority stock on Antibiotice Iasi, sources from the pharmaceuticals market ... More


Bulgarian drug maker Biovet launches co-generation facility

Bulgarian drug maker Biovet will launch in mid-April a co-generation power plant after conducting a 72-hour trial run. The 18MW GE turbine will produce industrial steam and electricity from exhaust gas emissions. Biovet ... More


Actavis Purchases Sindan Pharma With Almost EUR 150 Million

Islander pharmaceutical company Actavis purchased local oncology producer Sindan Pharma, with a transaction value of EUR 147.5 million. The transaction was mediated by JP Morgan. Following the purchase of Sindan, Actavis' incomes ... More


Romanian pharmaceutical market marked by Terapia, Sindan sale

Over the past few days the Romanian pharmaceutical market was marked by two important transactions: the sale of Sindan Bucharest and Terapia Cluj-Napoca, two of the leading Romanian medicine manufacturers, for a total USD 500 ... More


State enters spa renovation project

A shareholder agreement for the dilapidated spa Rimske Toplice was signed by Local Government and Regional Policy Minister Ivan Zagar and the spa's lessee representatives. The contract marks the first concrete step towards ... More


French dermal cosmetics represented in Belgrade

French company "Peirre Fabre" and representatives of the embassy of France promoted the strategy and new plans for development of the dermal cosmetics in Serbia and Montenegro. Dermal cosmetics is a new branch of dermatology ... More


Lavipharm sells products in Lebanon, Saudi Arabia

Castalia Laboratories Dermatologiques, a subsidiary of Athens-quoted Lavipharm SA, has launched its products in Lebanon and Saudi Arabia. The company's products are sold in Greece and abroad, including the USA, Taiwan, Korea, ... More